18F-choline PET/computed tomography and clinical parameters in the detection of significant prostate cancer in patients with increased prostate-specific antigen levels and previous negative biopsies-Reference-Cited by-同舟云学术

18F-choline PET/computed tomography and clinical parameters in the detection of significant prostate cancer in patients with increased prostate-specific antigen levels and previous negative biopsies

Published:2020-05-08 Issue: Volume:Publish Ahead of Print Page:
ISSN:0143-3636
Container-title:Nuclear Medicine Communications
language:en
Short-container-title:

Author:

Jiménez Londoño Germán Andrés,García Vicente Ana Maria,Noriega Álvarez Edel,Pena Pardo Francisco José,Amo-Salas Mariano,López Guerrero Mauricio Andres,Fúnez Mayorga Federico,Soriano Castrejón Ángel Maria

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Radiology Nuclear Medicine and imaging,General Medicine

Reference31 articles.

1. EAU-ESTRO-SIOG guidelines on prostate cancer. Part 1: screening, diagnosis, and local treatment with curative intent.;Mottet;Eur Urol,2017

2. Improving prostate cancer detection with an extended-core transrectal ultrasonography-guided prostate biopsy protocol.;Durkan;BJU Int,2002

3. Sextant localization of prostate cancer: comparison of sextant biopsy, magnetic resonance imaging and magnetic resonance spectroscopic imaging with step section histology.;Wefer;J Urol,2000

4. Complications after prostate biopsy: data from SEER-medicare.;Loeb;J Urol,2011

5. Can clinically significant prostate cancer be detected with multiparametric magnetic resonance imaging? A systematic review of the literature.;Fütterer;Eur Urol,2015

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Rendimiento de la PET/TC con 11C-colina en el seguimiento del cáncer de próstata;Revista Española de Medicina Nuclear e Imagen Molecular;2023-03